Add to ORKGlocated on the World Wide Web at: The online version of this article, along with updated information and services, is by guest on M arch 5, 201
Before 1989, when epoetin was introduced for dialysis-associated anemia, the use of intravenous (IV)...
Unresponsiveness to erythropoiesis-stimulating agents is a major limitation to the treatment of chem...
The content of this article has been reviewed by independent peer reviewers to ensure that it is bal...
located on the World Wide Web at: The online version of this article, along with updated information...
located on the World Wide Web at: The online version of this article, along with updated information...
Knowledge of the role of intravenous iron without the use of additional erythropoietic stimulating a...
Chemotherapy-induced anemia is often an important problem for cancer patients, and this complication...
Based on available literature and on the present review, IV iron administration to anemic cancer pat...
Abstract: Advanced-stage cancer patients often suffer from anemia that closely resembles the anemia ...
Background: Chronic anemia is a well-recognized complication of both cancer and cytotoxic treatments...
The content of this article has been reviewed by independent peer reviewers to ensure that it is bal...
This randomized trial evaluated ferric carboxymaltose without erythropoiesis-stimulating agents (ESA...
textabstractPurpose. To evaluate the effects of epoetin alfa on patient- reported outcomes (PROs) in...
Purpose. To evaluate the effects of epoetin alfa on patient- reported outcomes (PROs) in patients wi...
Epoetin alfa administered at 40,000 U once weekly (qw) to anemic cancer patients receiving chemother...
Before 1989, when epoetin was introduced for dialysis-associated anemia, the use of intravenous (IV)...
Unresponsiveness to erythropoiesis-stimulating agents is a major limitation to the treatment of chem...
The content of this article has been reviewed by independent peer reviewers to ensure that it is bal...
located on the World Wide Web at: The online version of this article, along with updated information...
located on the World Wide Web at: The online version of this article, along with updated information...
Knowledge of the role of intravenous iron without the use of additional erythropoietic stimulating a...
Chemotherapy-induced anemia is often an important problem for cancer patients, and this complication...
Based on available literature and on the present review, IV iron administration to anemic cancer pat...
Abstract: Advanced-stage cancer patients often suffer from anemia that closely resembles the anemia ...
Background: Chronic anemia is a well-recognized complication of both cancer and cytotoxic treatments...
The content of this article has been reviewed by independent peer reviewers to ensure that it is bal...
This randomized trial evaluated ferric carboxymaltose without erythropoiesis-stimulating agents (ESA...
textabstractPurpose. To evaluate the effects of epoetin alfa on patient- reported outcomes (PROs) in...
Purpose. To evaluate the effects of epoetin alfa on patient- reported outcomes (PROs) in patients wi...
Epoetin alfa administered at 40,000 U once weekly (qw) to anemic cancer patients receiving chemother...
Before 1989, when epoetin was introduced for dialysis-associated anemia, the use of intravenous (IV)...
Unresponsiveness to erythropoiesis-stimulating agents is a major limitation to the treatment of chem...
The content of this article has been reviewed by independent peer reviewers to ensure that it is bal...